Investing.com – U.K. equities were higher at the close on Friday, as gains in the Pharmaceuticals & Biotech, Tobacco and Aerospace & Defense sectors propelled shares higher. At...
Hikma Pharmaceuticals PLC (LON:HIK) said the US Food and Drug Administration (FDA) has approved Kloxxado, its emergency treatment of known or suspected opioid overdose. It can be...
It has been hard to keep AstraZeneca PLC (LON:AZN) out of the news and it will get further attention on Friday when it releases a first-quarter trading update. UBS is forecasting...
Vaccines manufactured by three groups have so far been approved in the UK. They include:AstraZeneca (LON:AZN) (NASDAQ:AZN)/ Oxford University;BioNTech (NASDAQ:BNTX) / Pfizer...
Recent positive news about a COVID-19 vaccine has put the limelight on health-care and pharmaceutical companies, especially BioNTtech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA) and...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 748.00 | 755.00 | 747.00 | -2.50 | -0.33% | 60.92K | London | |||
| 196.40 | 199.20 | 191.20 | +7.00 | +3.70% | 874.03K | London | |||
| 103.40 | 106.00 | 100.80 | -1.40 | -1.34% | 858.82K | London | |||
| 3,112.50 | 3,172.50 | 3,106.00 | -34.5 | -1.10% | 2.46M | London | |||
| 330.40 | 334.30 | 324.90 | +6.10 | +1.88% | 47.76M | London | |||
| 327.65 | 330.45 | 325.35 | -1.45 | -0.44% | 28.78M | London | |||
| 2.10 | 2.10 | 2.00 | +0.040 | +1.93% | 18.04M | London | |||
| 1,532.00 | 1,551.50 | 1,519.50 | +3.00 | +0.20% | 1.07M | London | |||
| 21.45 | 21.75 | 20.35 | +1.40 | +6.98% | 5.01M | London | |||
| 359.00 | 376.50 | 358.00 | -15.00 | -4.01% | 304.43K | London | |||
| 416.90 | 420.60 | 416.90 | -0.40 | -0.10% | 4.57M | London | |||
| 6,092.00 | 6,148.00 | 6,029.00 | -27.0 | -0.44% | 1.97M | London | |||
| 588.00 | 593.00 | 583.00 | -2.20 | -0.37% | 1.69M | London | |||
| 1,407.40 | 1,413.80 | 1,401.60 | +4.00 | +0.28% | 4.99M | London | |||
| 132.50 | 133.50 | 130.40 | +0.70 | +0.53% | 954.02K | London |
Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products across the Middle East and North Africa (MENA) region and other markets. The Company sells specialized generic injectable products across the globe. It also sells non-injectable generic products in the United States, supplying over 300 products in different dosage strengths and forms. The Company's other businesses comprise Arab Medical Containers, a manufacturer of plastic specialized medicinal sterile containers, International Pharmaceuticals Research Centre, which conducts bio-equivalency studies, and the active pharmaceutical ingredient (API) manufacturing division of Hikma Pharmaceuticals Limited Jordan.
